King, T. H., Kemmler, C. B., Guo, Z., Mann, D., Lu, Y., Coeshott, C., . . . Apelian, D. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationKing, Thomas H., et al. A Whole Recombinant Yeast-based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance. Public Library of Science (PLoS).
MLA (9th ed.) CitationKing, Thomas H., et al. A Whole Recombinant Yeast-based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance. Public Library of Science (PLoS).